Form EFFECT Anixa Biosciences Inc
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 30, 2025 5:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Anixa shares Phase 1 data on breast cancer vaccine and CAR-T therapy
- Neuphoria Responds to the announcement made by London-listed Scancell Holdings plc
- Stonegate Updates Coverage on Burcon Nutrascience Corporation (BU) 4Q26
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
